Cano Health’s (CANO) Sell Rating Reaffirmed at UBS Group

UBS Group restated their sell rating on shares of Cano Health (NYSE:CANO) in a research note published on Friday, Benzinga reports. UBS Group currently has a $3.75 price objective on the stock, down from their previous price objective of $12.00.

CANO has been the topic of several other research reports. Citigroup downgraded Cano Health from a buy rating to a neutral rating and dropped their price objective for the stock from $4.00 to $0.80 in a research note on Friday, August 11th. Jefferies Financial Group downgraded Cano Health from a buy rating to a hold rating in a research note on Friday, August 11th. Two analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of Hold and an average price target of $2.21.

Cano Health Stock Performance

Shares of Cano Health stock opened at $8.13 on Friday. The company has a market capitalization of $43.95 million, a PE ratio of -0.04 and a beta of 0.43. Cano Health has a 12 month low of $5.27 and a 12 month high of $226.00. The company has a current ratio of 0.40, a quick ratio of 0.49 and a debt-to-equity ratio of 3.95. The stock’s fifty day simple moving average is $2.21 and its 200 day simple moving average is $1.50.

Institutional Trading of Cano Health

A number of hedge funds and other institutional investors have recently modified their holdings of CANO. Ground Swell Capital LLC acquired a new stake in shares of Cano Health in the first quarter valued at about $27,000. SG Americas Securities LLC grew its holdings in Cano Health by 875.2% during the third quarter. SG Americas Securities LLC now owns 111,346 shares of the company’s stock worth $28,000 after purchasing an additional 99,928 shares during the period. Apollon Wealth Management LLC grew its holdings in Cano Health by 78.9% during the fourth quarter. Apollon Wealth Management LLC now owns 22,360 shares of the company’s stock worth $31,000 after purchasing an additional 9,860 shares during the period. GSA Capital Partners LLP grew its holdings in Cano Health by 64.8% during the fourth quarter. GSA Capital Partners LLP now owns 23,456 shares of the company’s stock worth $32,000 after purchasing an additional 9,224 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in Cano Health by 49.6% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 36,687 shares of the company’s stock worth $33,000 after purchasing an additional 12,159 shares during the period. Institutional investors and hedge funds own 35.99% of the company’s stock.

About Cano Health

Cano Health, Inc provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement.